0001213900-22-073942.txt : 20221118
0001213900-22-073942.hdr.sgml : 20221118
20221118193345
ACCESSION NUMBER: 0001213900-22-073942
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221114
FILED AS OF DATE: 20221118
DATE AS OF CHANGE: 20221118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WOUDENBERG MICHAEL
CENTRAL INDEX KEY: 0001817884
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39685
FILM NUMBER: 221403210
MAIL ADDRESS:
STREET 1: C/O INMED PHARMACEUTICALS INC.
STREET 2: SUITE 310 - 815 HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001728328
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
BUSINESS PHONE: (604) 669-7207
MAIL ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
4/A
1
ownership.xml
X0306
4/A
2022-11-14
2022-11-15
0
0001728328
InMed Pharmaceuticals Inc.
INM
0001817884
WOUDENBERG MICHAEL
C/O INMED PHARMACEUTICALS INC.
310-815 WEST HASTINGS ST.
VANCOUVER
A1
V6C1B4
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Operating Officer
Employee Stock Option (Right to Buy)
2.78
2022-11-14
4
D
0
7500
0.00
D
2027-11-13
Common shares
7500
3842
D
The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.
On September 7, 2022, the Issuer's common stock was reverse split on a 1-for-25 basis. This number reflects that reverse stock split.
On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 7,500 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 3,842 derivative securities of the Issuer.
/s/ Eric A. Adams, attorney-in-fact for Mr. Michael Woudenberg
2022-11-18